CLINICAL_TRIALS
research
· 2025-10-02
Clinical Trial Update: Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer [Phase 2]
Summary
This is a Phase 2 clinical trial evaluating inguinal node-sparing radiotherapy for patients with early-stage anal canal cancer, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AHS Cancer Control Alberta | Conditions: Anal Canal Cancer | Phase 2 | Status: RECRUITING